etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide
etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide
etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide
etoposide accord healthcare 20 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - etoposide 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - etoposide 20 mg/ml - etoposide
etoposide injection liquid
teva canada limited - etoposide - liquid - 20mg - etoposide 20mg - antineoplastic agents
etoposide injection, usp solution
strides pharma canada inc - etoposide - solution - 20mg - etoposide 20mg - antineoplastic agents
etoposide 20 mg/ml concentrate for soln for inf
cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).
etoposide 100mg/5ml concentrate for solution for infusion vials
actavis uk ltd - etoposide - solution for infusion - 20mg/1ml
etoposide 20mg/ml concentrate for solution for infusion concentrate for solution for infusion
accord healthcare limited - etoposide - concentrate for solution for infusion - 20mg/ml
toposar- etoposide injection, solution, concentrate
teva parenteral medicines, inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - toposar (etoposide injection) is indicated in the management of the following neoplasms: toposar (etoposide injection) in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. toposar is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.